COVID-19
COVID Cases Increasing Across Most of the Country
As of July 29, COVID-19 cases are increasing in at least 40 states. No state is reporting declining cases.
AUGUST 12, 2025
NCCN Guidelines Recommend mAbs for COVID-19 PrEP in People With Cancer
NCCN Guidelines for the Prevention and Treatment of Cancer-Related Infections advise clinicians recommend mAbs to protect against COVID-19.
AUGUST 5, 2025
America Still Seeing Many Hospitalizations, Deaths from SARS-CoV-2
The CDC estimates from Oct. 1, 2024 through June 7, 2025, COVID-19 caused an estimated 9.8 million to 16.1 million illnesses, 2.4 million to 3.8 million outpatient visits, 270,000 to 440,000 hospitalizations and 32,000 to 51,000 deaths.
JULY 25, 2025
Long Half-Life Seen With Novel mAb for COVID-19
The half life of the novel mAb candidate, VYD2311, may be six months or more.
JULY 8, 2025
IDSA, Others Join Lawsuit Against RFK Jr. Over Vaccine Policy Changes
IDSA, APHA, AAP, ACP, MPHA and SMFM join lawsuit against RFK Jr. alleging unilateral changes to vaccine policy unlawful.
JULY 8, 2025
Steroid Use During COVID-19 Creates Perfect Storm for Fungal Infections
Environmental factors; high rates of diabetes; and a widespread use of steroids during the COVID-19 pandemic appeared to be a perfect storm for mucormycosis cases.
JULY 7, 2025
Pemivibart Appears to Prevent COVID-19 Infection in CLL
Pemgarda is well tolerated and appears effective in preventing symptomatic COVID-19 infection among patients with chronic lymphocytic leukemia (CLL), who can be severely immunocompromised, according to a study reported at MAD-ID 2025.
JUNE 6, 2025
Ensitrelvir Reduced the Risk for COVID-19 by 67%
Ensitrelvir, an antiretroviral being developed to prevent COVID-19, reduced the risk of developing the infection by 67% in uninfected people after exposure to SARS-CoV-2 compared with placebo at day 10.
APRIL 16, 2025
Long COVID Disproportionately Affects Women, Study Says
Women are significantly more likely to develop long COVID than men, with middle-aged women being at the highest risk.
APRIL 9, 2025
FDA Extends Expiration Dates for COVID-19 Tests
FDA extends expiration date for some COVID-19 tests.
MARCH 24, 2025
Pemgarda Neutralizing Activity Remains Stable Against Current Dominant SARS-CoV-2 Strain
Pemivibart, a next-generation COVID-19 monoclonal antibody (mAb), is still showing clinically meaningful in vitro neutralization data against the currently dominant LP.8.1 variant of SARS-CoV-2, according to data provided to the company by the FDA.
MARCH 7, 2025
CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for Older or Immunocompromised People
The CDC endorsed the recommendation of the ACIP for people 65 and older and certain immunocompromised individuals to receive a second dose of the 2024-2025 COVID-19 vaccine six months after their first dose.
NOVEMBER 6, 2024
